New grad roles at CatalYm
CatalYm is a clinical-stage biotechnology company developing antibody-based immunotherapies for solid tumors and cancer-associated cachexia. Its lead antibody, visugromab, neutralizes GDF-15 to address immune resistance and restore anti-tumor activity.
- Industry
- Biotech & Pharma, Healthcare & Health Tech
- Company size
- 11–50 employees
- Stage
- Series D
- Open roles
- 3
No current roles
Clear a filter to see every role.
Get new CatalYm new grad roles by email
Free account. Get new CatalYm new grad roles by email or push the minute they post.
